The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27894044 |
37 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. |
University of Kwazulu-Natal |
18023192 |
2 |
Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors. |
Abx Advanced Biochemical Compounds |
16250647 |
71 |
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. |
Universit£ |
18851913 |
11 |
Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors. |
Lund University |
19469479 |
44 |
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor. |
Universita Di Pisa |
18651727 |
15 |
Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site. |
Johannes Gutenberg University |
28606760 |
57 |
Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors. |
Amgen |
26950400 |
37 |
Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors. |
Tianjin University of Science and Technology |
26398141 |
14 |
Evaluation of 2-indolcarbohydrazones as potent a-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions. |
Universiti Teknologi Mara (Uitm) |
25511999 |
3 |
Design, Synthesis, and Biological Evaluation of Novel Benzoyl Diarylamine/ether Derivatives as Potential Anti-HIV-1 Agents. |
Shandong University |
26364932 |
22 |
Structure and Inhibition of Microbiome ß-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. |
University of North Carolina At Chapel Hill |
26158339 |
24 |
Type II Inhibitors Targeting CDK2. |
University of Oxford |